Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05745623
Status:
RECRUITING
Last Update Posted:
2023-02-27
First Post:
2023-02-16
Brief Title:
A Phase 2 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Sponsor:
Beijing InnoCare Pharma Tech Co Ltd
Organization:
Beijing InnoCare Pharma Tech Co Ltd
Organization Data
Organization:
Beijing InnoCare Pharma Tech Co Ltd
Class:
INDUSTRY
Study ID:
ICP-CL-00505
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing InnoCare Pharma Tech Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None